Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBridge Biosciences (NBP) Current Leases (2019 - 2022)

NovaBridge Biosciences (NBP) has disclosed Current Leases for 4 consecutive years, with $3.4 million as the latest value for Q4 2022.

  • Quarterly Current Leases fell 29.77% to $3.4 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $3.4 million through Dec 2022, down 29.77% year-over-year, with the annual reading at $3.5 million for FY2022, 27.82% down from the prior year.
  • Current Leases for Q4 2022 was $3.4 million at NovaBridge Biosciences, down from $4.8 million in the prior quarter.
  • The five-year high for Current Leases was $4.8 million in Q4 2021, with the low at $965782.4 in Q4 2019.
  • Average Current Leases over 4 years is $2.6 million, with a median of $2.3 million recorded in 2020.
  • The sharpest move saw Current Leases surged 294.52% in 2021, then decreased 29.77% in 2022.
  • Over 4 years, Current Leases stood at $965782.4 in 2019, then rose by 25.9% to $1.2 million in 2020, then soared by 294.52% to $4.8 million in 2021, then decreased by 29.77% to $3.4 million in 2022.
  • According to Business Quant data, Current Leases over the past three periods came in at $3.4 million, $4.8 million, and $1.2 million for Q4 2022, Q4 2021, and Q4 2020 respectively.